EUR/USD 1.08032
0.165%
Gold 2905.77
-0.172%
Oil 66.220
0.304%
USD/JPY 147.499
-0.324%
GBP/USD 1.28875
0.052%
GBP/JPY 190.092
-0.230%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On March 7, Goldman Sachs published a research report stating that JD Health (06618.HK)s revenue growth in the second half of last year was in line with expectations, but the adjusted operating profit was lower than forecast. Net profit has also improved due to rising interest or other income. The report mentioned that JD Health managements profit guidance for 2025 is quite conservative, with sales expected to grow by double digits year-on-year and operating profit to remain flat year-on-year, as the company will focus on investing more in offline on-demand delivery and artificial intelligence initiatives in first-tier cities. Operating profit may decline year-on-year due to reduced interest income. In the long run, management is confident in further expanding its share and competitiveness in the online or offline pharmacy market.On March 7, Wang Yi said that we welcome all sectors of the two countries to strengthen exchanges, deepen mutually beneficial cooperation, and improve national sentiments, which are in line with the long-term interests of both sides. Regarding some specific concerns of the Japanese side, China will uphold a responsible attitude and properly handle them in accordance with laws and regulations.SpaceX will conduct a thorough investigation into the explosion and disintegration of the Starships second-stage spacecraft and cooperate with the Federal Aviation Administration (FAA).Hong Kong-listed pharmaceutical stocks strengthened, with Everest Medicines (01952.HK) rising more than 14%, EMTECH (02160.HK) rising more than 8%, and Fosun Pharma (02137.HK) rising 7.4%.Hong Kong stocks rose, the Hang Seng Tech Index turned positive, and the Hang Seng Index narrowed its decline to 0.29%. It had previously fallen by more than 1%.

Before UK Employment And Japan GDP Data, GBP/JPY Recovers Above 158.50

Daniel Rogers

Feb 13, 2023 14:37

 GBP:JPY.png

 

In the early hours of Tokyo, GBP/JPY surpassed 158.50. After Friday's significant swings, it is anticipated that the cross's volatility will decrease. As the likelihood of scholar Kazuo Ueda being appointed the next Governor of the Bank of Japan (BoJ) grew, the Japanese Yen witnessed extreme volatility.

 

According to the Nikkei Asian Review, the Japanese Cabinet is anticipated to appoint Kazuo Ueda as the next Governor of the Bank of Japan (BoJ) when Haruhiko Kuroda steps down in April. According to sources, the Japanese government would appoint former FSA Chief Himino and BoJ Executive Director Shinichi Uchida as Deputy BoJ Governor.

 

The announcement prompted the Japanese Yen to climb perpendicularly, but Kazuo Ueda's assertion that the current monetary policy was appropriate halted the increase. Prime Minister Fumio Kishida of Japan reaffirmed that the administration will consider ending the decade-long expansionary approach under the new leadership of the Bank of Japan. Kazuo Ueda's divergent position on monetary policy diminished the likelihood of a withdrawal from accommodative monetary policy.

 

Investors are awaiting the Japan GDP (Q4) report on Tuesday. The growth of economic data is 2% annually and 0.5% quarterly.

 

British investors await employment data to determine the direction of the Pound. The three-month unemployment rate stays unchanged at 3.7%. Without incentives, average earnings are expected to increase by 6.5%. The Bank of England (BoE), which is battling inflation, may confront additional obstacles.

 

If we achieve our goal of halving inflation this year, we will have some of the best growth prospects in Europe, according to the British minister of finance, Jeremy Hunt.

Suggestion